Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,289 | 24,068 | 18,574 | 78,596 | 59,189 |
| Depreciation Amortization | 93,243 | 64,017 | 33,444 | 110,818 | 83,314 |
| Income taxes - deferred | -4,796 | 2,135 | 630 | 4,499 | 2,424 |
| Accounts receivable | 4,562 | 1,200 | 1,158 | -11,708 | -6,889 |
| Other Working Capital | 54,944 | 26,480 | 8,910 | -14,915 | -9,063 |
| Other Operating Activity | 21,960 | -7 | -8,387 | 12,480 | 10,612 |
| Operating Cash Flow | $188,202 | $117,893 | $54,329 | $179,770 | $139,587 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -37,139 | -35,406 | N/A | N/A | N/A |
| PPE Investments | -78,263 | -11,328 | 39,069 | -674,402 | -434,451 |
| Other Investing Activity | 1,520 | -114 | 0 | 11,059 | -23,818 |
| Investing Cash Flow | $-113,882 | $-46,848 | $39,069 | $-663,343 | $-458,269 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 581,582 | 468,082 | 306,582 | 1,605,564 | 1,227,412 |
| Debt Repayment | -614,006 | -490,319 | -382,847 | -1,143,908 | -981,465 |
| Common Stock Issued | 532 | 335 | 107 | 103,457 | 103,705 |
| Common Stock Repurchased | -34,118 | -34,118 | -13,946 | -40,869 | -27,946 |
| Dividend Paid | -6,621 | -4,414 | -2,207 | -3,260 | -1,376 |
| Other Financing Activity | -768 | -496 | -419 | -8,634 | 21,129 |
| Financing Cash Flow | $-73,399 | $-60,930 | $-92,730 | $512,350 | $341,459 |
| Exchange Rate Effect | -874 | -77 | 238 | -3 | -23 |
| Beginning Cash Position | 75,983 | 75,983 | 75,983 | 47,209 | 47,209 |
| End Cash Position | 76,030 | 86,021 | 76,889 | 75,983 | 69,963 |
| Net Cash Flow | $47 | $10,038 | $906 | $28,774 | $22,754 |
| Free Cash Flow | |||||
| Operating Cash Flow | 188,202 | 117,893 | 54,329 | 179,770 | 139,587 |
| Capital Expenditure | -337,265 | -231,731 | -141,262 | -740,004 | -478,096 |
| Free Cash Flow | -149,063 | -113,838 | -86,933 | -560,234 | -338,509 |